Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Roluperidone (CYR-101) is a novel cyclic amide derivative. It has high equipotent affinities for 5-HT2A and σ2 receptors (Ki of 7.53 nM and 8.19 nM for 5-HT2A and σ2).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 44.00 | |
5 mg | In stock | $ 97.00 | |
10 mg | In stock | $ 155.00 | |
25 mg | In stock | $ 278.00 | |
50 mg | In stock | $ 455.00 | |
100 mg | In stock | $ 672.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 98.00 |
Description | Roluperidone (CYR-101) is a novel cyclic amide derivative. It has high equipotent affinities for 5-HT2A and σ2 receptors (Ki of 7.53 nM and 8.19 nM for 5-HT2A and σ2). |
Targets&IC50 | σ2:8.19 nM(ki), 5-HT2A:7.53 nM(ki) |
In vitro | Roluperidone shows binding affinity for α1-adrenergic receptors. Which low or no affinity for muscarinic, cholinergic, and histaminergic receptors. Although Roluperidone (CYR-101) has no affinities for pre- or postsynaptic dopaminergic receptors, it is probable that sigma-2 receptors are implicated in the modulation of dopamine and glutamatergic pathways and in calcium neuronal modulation[1]. |
Synonyms | CYR-101, MIN-101, MT-210 |
Molecular Weight | 366.43 |
Formula | C22H23FN2O2 |
CAS No. | 359625-79-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 0.1 mg/mL (insoluble)
DMSO: 33.33 mg/mL (90.96 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Roluperidone 359625-79-9 GPCR/G Protein Neuroscience Sigma receptor 5-HT Receptor MIN101 CYR-101 5-hydroxytryptamine Receptor MT 210 Inhibitor MIN-101 MT-210 CYR 101 inhibit MT210 MIN 101 Sigma Receptor CYR101 Serotonin Receptor inhibitor